Logo IFCT

Select your language

  • FR

IFCT-0802

  • Publications:
  • Randomized phase II-III study of bevacizumab in combination with chemotherapy in previously untreated extensive small-cell lung cancer: Results from the IFCT-0802 trial
  • Randomized Phase II-III Study of Bevacizumab in Combination with Chemotherapy in Previously Untreated Extensive Small-Cell Lung Cancer: Results from the IFCT-0802 Trial
  • Reply to the letter to the editor 'Flaws in the trial design of IFCT-0802' by Gyawali et al
  • Synopsis: IFCT-0802_Synopsis_211209.pdf

Intergroupe Francophone de Cancérologie Thoracique

Siège social
10 rue de la Grange-Batelière
75009 PARIS

Standard : 01.56.81.10.45
Recherche Clinique : 01.56.81.10.46
Permanence téléphonique du lundi au vendredi : 9h-13h / 14h-17h

Informations

  • Mentions légales
  • Avertissement

Suivez-nous

  • TwitterTwitter
  • LinkedIn
© IFCT 2025 - IFCT_TOUS_DROITS_RESERVES
Contact Devenir membre Espace membre E-lettre Deconnexion